Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Taxes: 2012-2015

Historic Change in Taxes for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Dec 2015 value amounting to -$92,000.

  • Amphastar Pharmaceuticals' Change in Taxes fell 351.29% to -$2.5 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$5.8 million, marking a year-over-year decrease of 236.88%. This contributed to the annual value of -$92,000 for FY2015, which is 116.46% down from last year.
  • Amphastar Pharmaceuticals' Change in Taxes amounted to -$92,000 in FY2015, which was down 116.46% from $559,000 recorded in FY2014.
  • In the past 5 years, Amphastar Pharmaceuticals' Change in Taxes registered a high of $559,000 during FY2014, and its lowest value of -$2.4 million during FY2012.
  • Moreover, its 3-year median value for Change in Taxes was -$92,000 (2015), whereas its average is $98,000.
  • In the last 5 years, Amphastar Pharmaceuticals' Change in Taxes surged by 423.12% in 2014 and then slumped by 116.46% in 2015.
  • Amphastar Pharmaceuticals' Change in Taxes (Yearly) stood at -$2.4 million in 2012, then skyrocketed by 92.79% to -$173,000 in 2013, then skyrocketed by 423.12% to $559,000 in 2014, then tumbled by 116.46% to -$92,000 in 2015.